William Blair upgraded Zealand Pharma (ZLDPF) to Outperform from Market Perform.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZLDPF:
- Zealand Pharma removed from European Conviction List at Goldman Sachs
- Zealand Pharma initiated with a Market Perform at William Blair
- Zealand Pharma price target lowered to DKK 1,050 from DKK 1,080 at Berenberg
- Zealand Pharma’s Earnings Call: Clinical Gains and Challenges
- Zealand Pharma price target lowered to DKK 750 from DKK 755 at Morgan Stanley